Page last updated: 2024-10-22

am 251 and Pancreatic Neoplasms

am 251 has been researched along with Pancreatic Neoplasms in 1 studies

AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fogli, S1
Nieri, P1
Chicca, A1
Adinolfi, B1
Mariotti, V1
Iacopetti, P1
Breschi, MC1
Pellegrini, S1

Other Studies

1 other study available for am 251 and Pancreatic Neoplasms

ArticleYear
Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism.
    FEBS letters, 2006, Mar-20, Volume: 580, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Cannabinoids; Cell Line, Tumor; Cell Proliferation; Humans; Inhibi

2006